‘Impossible' To Prepare UK Supply Chain For October No-Deal Brexit
Executive Summary
The UK parliament's Exiting the EU Committee has heard strong words from industry representatives who say that the sector will not be ready for a no-deal Brexit in in October and that such a scenario would result in stockpiling problems, drug shortages and safety issues.
You may also be interested in...
Decisive Action Called For On EU Drug Shortages
A public health advocacy group in the EU has issued tangible recommendations to address the perennial problem of drug shortages in the region.
Brexit Stakes Rise As New UK Prime Minister Takes Over
The UK has a new prime minister in Boris Johnson, who is likely to surround himself with strongly pro-Brexit ministers. The life sciences industry will need to continue lobbying for its interests to be protected in the event of a no-deal exit.
No-Deal Brexit 'Very Bad' For Business And Patients
Peter Martin, COO of Norgine, is concerned about the ‘mood music’ in the political environment in the UK, and warns about the risks of the UK leaving the EU without a deal in place.